NNC126-0083

DRUG4 trials

Sponsors

Novo Nordisk A/S

Conditions

Adult Growth Hormone DeficiencyGrowth Hormone Deficiency in ChildrenGrowth Hormone DisorderHealthy

Phase 1

Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

CompletedNCT00722540

Novo Nordisk A/SGrowth Hormone Disorder, Healthy

Start: 2008-07-31End: 2009-04-30Updated: 2017-02-08

Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®

CompletedNCT01034202

Novo Nordisk A/SGrowth Hormone Disorder, Healthy

Start: 2007-08-31End: 2008-01-31Updated: 2017-02-09

Phase 2

Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

CompletedNCT00715689

Novo Nordisk A/SAdult Growth Hormone Deficiency, Growth Hormone Disorder

Start: 2008-07-31End: 2009-03-31Updated: 2017-02-08

A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone

CompletedNCT00936403

Novo Nordisk A/SGrowth Hormone Deficiency in Children, Growth Hormone Disorder

Start: 2009-08-31End: 2010-07-31Updated: 2017-02-08

Related Papers

Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin<sup>®</sup> in Children and Adults.

2021-04-176 citations